Table III: 2019 Medicare Drug Fee Schedule* CY st Quarter Average Sales Price (ASP) Data Plus 6 Percent

Size: px
Start display at page:

Download "Table III: 2019 Medicare Drug Fee Schedule* CY st Quarter Average Sales Price (ASP) Data Plus 6 Percent"

Transcription

1 Table III: 2019 Medicare Drug Fee Schedule* CY st Quarter Average Sales Price (ASP) Data Plus 6 Percent *The Medicare payments allowance limits are effective Jan. 1 thru March. 31, CY 2019 Effective Jan. 1 Through Mar. 31 Code Description Code Dosage ASP plus 6 percent J0129 Abatacept 10mg $51.61 J0130 Abciximab injection 10mg $1, J0133 Acyclovir, 5 mg 5mg $0.05 J0171 Adrenalin epinephrin inject 0.1mg $0.74 J0207 Amifostine 500mg $ J0256 Alpha 1 proteinase inhibitor 10mg $4.55 J0280 Aminophyllin 250 MG inj 250mg $7.02 J0289 Amphotericin b liposome inj 10mg $22.19 J0295 Ampicillin sodium per 1.5 gm 1.5gm $2.62 J0360 Hydralazine hcl injection 20mg $2.58 J0456 Azithromycin 500mg $2.76 J0461 Atropine sulfate injection 0.01mg $0.07 J0475 Baclofen 10 MG injection 10mg $ J0476 Baclofen intrathecal trial 50mcg $44.35 J0480 Basiliximab 20mg $3, J0490 Belimumab 10mg $44.16 J0500 Dicyclomine injection 20mg $69.65 J0515 Inj benztropine mesylate 1mg $18.67 J0570 Buprenorphine implant 74.2mg $1, J0583 Bivalirudin 1mg $0.80 J0585 Botulinum toxin a per unit 1unit $6.14 J0587 Botulinum toxin type B 100units $12.00 J0592 Buprenorphine hydrochloride 0.1mg $4.15 J0595 Butorphanol tartrate 1 mg 1mg $2.62 J0600 Edetate calcium disodium inj 1000mg $5, J0610 Calcium gluconate injection 10ml $4.36 J0630 Calcitonin salmon injection 400units $2, J0636 Inj calcitriol per 0.1 mcg 0.1mcg $0.45 J0637 Caspofungin acetate 5mg $10.02 J0640 Leucovorin calcium injection 50mg $3.35 J0690 Cefazolin sodium injection 500mg $0.83 J0692 Cefepime HCl for injection 500mg $2.47 J0694 Cefoxitin sodium injection 1gm $3.54 J0696 Ceftriaxone sodium injection 250mg $0.65 J0697 Sterile cefuroxime injection 750mg $2.09 J0702 Betamethasone acet&sod phosp 3mg $6.89 J0713 Inj ceftazidime per 500 mg 500mg $2.10 J0717 Certolizum Pegol Inj 1mg $7.89 J0720 Chloramphenicol sodium injec 1gm $39.34 J0725 Chorionic gonadotropin/1000u 1,000units $22.60 J0740 Cidofovir injection 375mg $ J0743 Cilastatin sodium injection 250mg $6.95 J0770 Colistimethate sodium inj 150mg $15.30

2 J0780 Prochlorperazine injection 10mg $10.06 J0800 Corticotropin injection 1-40units $3, J0882 Darbepoetin alfa, non-esrd 1mcg $3.83 J0885 Non esrd epoetin alpha inj 1,000units $11.95 J0895 Deferoxamine mesylate inj 500mg $9.62 J0897 Denosumab injection 1 mg $18.61 J1000 Depo-estradiol cypionate inj 5mg $21.94 J1020 Methylprednisolone 20 MG inj 20mg $4.01 J1030 Methylprednisolone 40 MG inj 40mg $6.60 J1040 Methylprednisolone 80 MG inj 80mg $12.86 J1100 Dexamethasone sodium phos 1mg $0.11 J1110 Inj dihydroergotamine mesylt 1mg $14.18 J1120 Acetazolamid sodium injectio 50mg $14.18 J1160 Digoxin injection 0.5mg $4.87 J1165 Phenytoin sodium injection 50mg $1.04 J1190 Dexrazoxane HCl injection 250mg $ J1200 Diphenhydramine hcl injectio 1-50mg $0.54 J1205 Chlorothiazide sodium inj 500mg $73.20 J1230 Methadone injection 10mg $73.20 J1245 Dipyridamole injection 10mg $1.67 J1250 Inj dobutamine HCL/250 mg 250mg $7.32 J1265 DopAMIne injection 40mg $0.82 J1270 Injection, doxercalciferol 1mcg $0.47 J1325 Epoprostenol injection 0.5mg $16.16 J1335 Ertapenem injection 500mg $53.61 J1364 Erythro lactobionate /500 MG 500mg $78.87 J1410 Inj estrogen conjugate 25 MG 25mg $ J1430 Ethanolamine oleate 100 mg 100mg $ J1450 Fluconazole 200mg $5.57 J1566 Inj immune globulin, lyophilzed 500mg 500mg $43.11 J1570 Ganciclovir sodium injection 500mg $56.25 J1580 Garamycin gentamicin inj 80mg $1.69 J1610 Glucagon hydrochloride/1 MG 1mg $ J1626 Granisetron HCl injection 100mcg $0.44 J1630 Haloperidol injection 5mg $1.09 J1631 Haloperidol decanoate inj 50mg $17.39 J1642 Inj heparin sodium per 10 u 10units $0.18 J1644 Inj heparin sodium per 1000u 1000units $0.20 J1645 Dalteparin sodium 2500I.U. $13.94 J1650 Inj enoxaparin sodium 10mg $0.77 J1652 Fondaparinux sodium 0.5mg $2.07 J1720 Hydrocortisone sodium succ i 100mg $12.99 J1740 Ibandronate sodium 1mg $55.44 J1742 Ibutilide fumarate injection 1mg $ J1745 Infliximab injection 10mg $76.95 J1756 Iron sucrose injection 1mg $0.24 J1786 Imuglucerase injection 10units $42.12 J1800 Propranolol injection 1mg $3.66 J1815 Insulin injection 5units $0.89 J1817 Insulin for insulin pump use 50units $10.95 J1940 Furosemide injection 20mg $0.83 J1950 Leuprolide acetate /3.75 MG 3.75mg $1,188.99

3 J1955 Inj levocarnitine per 1 gm 1gm $20.56 J1956 Levofloxacin injection 250mg $1.47 J1980 Hyoscyamine sulfate inj 0.25mg $30.29 J2001 Lidocaine injection 10mg $0.05 J2010 Lincomycin injection 300mg $13.46 J2020 Linezolid injection 200mg $8.51 J2060 Lorazepam injection 2mg $0.73 J2150 Mannitol injection 50ml $3.80 J2185 Meropenem 100mg $1.03 J2210 Methylergonovin maleate inj 0.2mg $15.77 J2250 Inj midazolam hydrochloride 1mg $0.13 J2260 Inj milrinone lactate / 5 MG 5mg $1.40 J2310 Inj naloxone hydrochloride 1mg $17.72 J2353 Octreotide injection, depot 1mg $ J2354 Octreotide inj, non-depot 25mcg $0.91 J2400 Chloroprocaine hcl injection 30ml $28.78 J2405 Ondansetron hcl injection 1mg $0.17 J2430 Pamidronate disodium /30 MG 30mg $11.91 J2501 Paricalcitol 1mcg $0.64 J2505 Injection, pegfilgrastim 6mg 6mg $4, J2507 Pegloticase injection 1mg 1mg $2, J2510 Penicillin g procaine inj 600,000units $29.29 J2515 Pentobarbital sodium inj 50mg $48.29 J2543 Piperacillin/tazobactam 1.125gm $1.94 J2560 Phenobarbital sodium inj 120mg $39.20 J2597 Inj desmopressin acetate 1mcg $12.46 J2675 Inj progesterone per 50 MG 50mg $1.85 J2680 Fluphenazine decanoate 25 MG 25mg $15.44 J2690 Procainamide hcl injection 1gm $77.30 J2700 Oxacillin sodium injection 250mg $1.93 J2765 Metoclopramide hcl injection 10mg $1.92 J2770 Quinupristin/dalfopristin 500mg $ J2780 Ranitidine hydrochloride inj 25mg $5.06 J2783 Rasburicase 0.5mg $ J2788 Rho d immune globulin 50 mcg 50mcg $28.62 J2792 Rho(D) immune globulin h, sd 100IU $27.78 J2795 Ropivacaine HCl injection 1mg $0.09 J2810 Inj theophylline per 40 MG 40mg $0.33 J2820 Sargramostim injection 50mcg $38.96 J2916 Na ferric gluconate complex 12.5mg $1.94 J2920 Methylprednisolone injection 40mg $4.87 J2930 Methylprednisolone injection 125mg $6.93 J2997 Alteplase recombinant 1mg $87.75 J3010 Fentanyl citrate injection 0.1mg $0.83 J3101 Tenecteplase injection 1mg $ J3105 Terbutaline sulfate inj 1mg $2.68 J3230 Chlorpromazine hcl injection 50mg $30.34 J3240 Thyrotropin injection 0.9mg_1.1mg $1, J3250 Trimethobenzamide hcl inj 200mg $32.77 J3260 Tobramycin sulfate injection 80mg $2.91 J3262 Tocilizumab injection 1mg $4.93 J3285 Treprostinil, 1 mg 1mg $66.12

4 J3301 Triamcinolone acetonide inj 10mg $1.70 J3315 Triptorelin pamoate 3.75mg $ J3360 Diazepam injection 5mg $6.88 J3370 Vancomycin hcl injection 500mg $4.23 J3396 Verteporfin injection 0.1mg $10.98 J3410 Hydroxyzine hcl injection 25mg $6.36 J3420 Vitamin b12 injection 1000mcg $1.74 J3430 Vitamin k phytonadione inj 1mg $4.23 J3465 Injection, voriconazole 10mg $1.78 J3475 Inj magnesium sulfate 500mg $0.55 J3480 Inj potassium chloride 2meq $0.14 J3485 Zidovudine 10mg $1.51 J3486 Ziprasidone mesylate 10mg $10.10 J3489 Zoledronic acid 1mg $12.74 J7030 Normal saline solution infus 1000cc $2.52 J7040 Normal saline solution infus 500ML $1.26 J7042 5% dextrose/normal saline 500ML $1.00 J7050 Normal saline solution infus 250cc $0.63 J7060 5% dextrose/water 500ML $2.48 J7070 D5w infusion 1000cc $4.56 J7120 Ringers lactate infusion 1000cc $2.45 J7189 Factor viia recombinant 1mcg $2.08 J7190 Factor viii 1I.U. $1.08 J7192 Factor viii recombinant 1I.U. $1.30 J7193 Factor IX non-recombinant 1I.U. $1.14 J7194 Factor ix complex 1I.U. $1.43 J7195 Factor IX recombinant 1I.U. $1.50 J7197 Antithrombin iii injection 1I.U. $3.50 J7198 Anti-inhibitor 1I.U. $2.00 J7308 Aminolevulinic acid hcl top 354mg $ J7321 Hyalgan or Supartz, inj PER DOSE $79.91 J7323 Euflexxa, inj PER DOSE $ J7324 Orthovisc, inj PER DOSE $ J7325 Synvisc and Synvisc-One 1mg $11.86 J7500 Azathioprine oral 50mg 50mg $0.89 J7502 Cyclosporine oral 100 mg 100mg $2.45 J7504 Lymphocyte immune globulin 250mg $2, J7507 Tacrolimus oral per 1 MG 1mg $0.58 J7509 Methylprednisolone oral 4mg $0.40 J7511 Antithymocyte globuln rabbit 25mg $ J7515 Cyclosporine oral 25 mg 25mg $0.72 J7516 Cyclosporin parenteral 250mg 250mg $48.89 J7517 Mycophenolate mofetil oral 250mg $1.03 J7520 Sirolimus, oral 1mg $7.23 J7525 Tacrolimus injection 5mg $ J7608 Acetylcysteine inh sol u d 1gm $5.07 J7626 Budesonide inhalation sol mg $2.24 J7631 Cromolyn sodium inh sol u d 10mg $5.58 J7639 Dornase alpha inhal sol u d 1mg $47.79 J7644 Ipratropium brom inh sol u d 1mg $0.21 J7682 Tobramycin inhalation sol 300mg $39.67 J8510 Oral busulfan 2mg $24.13

5 J8520 Capecitabine, oral, 150 mg 150mg $1.15 J8521 Capecitabine, oral, 500 mg 500mg $3.67 J8530 Cyclophosphamide oral 25 MG 25mg $4.54 J8560 Etoposide oral 50 MG 50mg $75.76 J8610 Methotrexate oral 2.5 MG 2.5mg $0.38 J8700 Temozolomide 5mg $0.87 J9000 Doxorubic hcl 10 MG vl chemo 10mg $3.06 J9017 Arsenic trioxide 1mg $46.91 J9031 Bcg live intravesical vac per installation $ J9034 Bendeka inj 1mg $ J9040 Bleomycin sulfate injection 15units $28.77 J9045 Carboplatin injection 50mg $3.25 J9050 Carmus bischl nitro inj 200mg $4, J9060 Cisplatin 10 MG injection 10mg $1.85 J9065 Inj cladribine per 1 MG 1mg $21.88 J9070 Cyclophosphamide 500 MG inj 100mg $37.82 J9100 Cytarabine hcl 100 MG inj 100mg $0.77 J9120 Dactinomycin actinomycin d 0.5mg $1, J9145 Daratumumab inj 10mg $52.30 J9150 Daunorubicin 10mg $48.17 J9171 Docetaxel injection 1mg $1.34 J9176 Elotozumab inj 1mg $6.40 J9178 Inj, epirubicin hcl, 2 mg 2mg $1.19 J9181 Etoposide 10 MG inj 10mg $0.70 J9185 Fludarabine phosphate inj 50mg $79.51 J9190 Fluorouracil injection 500mg $1.79 J9200 Floxuridine injection 500mg $75.59 J9201 Gemcitabine HCl 200mg $5.93 J9202 Goserelin acetate implant 3.6mg $ J9205 Irinotecan liposome inj 1mg $45.65 J9206 Irinotecan injection 20mg $2.86 J9208 Ifosfomide injection 1gm $25.45 J9209 Mesna injection 200mg $2.10 J9211 Idarubicin hcl injection 5mg $32.80 J9214 Interferon alfa-2b inj 1millionunits $34.03 J9217 Leuprolide acetate suspnsion 7.5mg $ J9218 Leuprolide acetate injection 1mg $20.49 J9230 Mechlorethamine hcl inj 10mg $ J9245 Inj melphalan hydrochl 50 MG 50mg $ J9250 Methotrexate sodium inj 5mg $0.25 J9260 Methotrexate sodium inj 50mg $2.52 J9263 Oxaliplatin 0.5mg $0.19 J9268 Pentostatin injection 10mg $2, J9280 Mitomycin 5 MG inj 5mg $ J9293 Mitoxantrone hydrochl / 5 MG 5mg $27.58 J9295 Necitumumab inj 1mg $5.61 J9311 Inj, rixtuximab, hyaluronidase 10mg $46.64 J9312 Inj., rixtuximab, 10mg 10mg $95.40 J9320 Streptozocin injection 1gm $ J9325 talimogene loherparepvec 1million pfu $50.05 J9352 Trabectedin inj 0.1mg $ J9355 Trastuzumab 10mg $107.00

6 J9360 Vinblastine sulfate inj 1mg $3.69 J9370 Vincristine sulfate 1 MG inj 1mg $4.95 J9390 Vinorelbine tartrate/10 mg 20mg $8.27 J9395 Injection, Fulvestrant 25mg $97.49 Q0167 Dronabinol 2.5mg oral 2.5mg $1.17 Q5103 Infliximab biosimiolar inj, inflectra 10mg $57.28 Q5104 Injection, renflexis 10mg $61.90 This information is from the CMS website dated December 12, 2018.

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

The following are J Code requirements

The following are J Code requirements The following are J Code requirements J Codes 20610 Arthrocentesis, aspiration and/or injection; major joint or bursa (eg, shoulder, hip, knee joint, subacromial bursa) A9579 Injection, gadolinium based

More information

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364 G0333 INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.470 J0285 INJECTION, AMPHOTERICIN B 50 MG $10.280 J0287 INJECTION, AMPHOTERICIN B LIPID COMPLEX 10 MG $21.850 J0288

More information

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018 G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.068 J0285 INJECTION, AMPHOTERICIN B 50 MG $32.987 J0287 INJECTION,

More information

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019 G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.048 J0285 INJECTION, AMPHOTERICIN B 50 MG $31.668 J0287 INJECTION,

More information

Injectables/Medications Administered Under the Medical Benefit Authorization NOT Required List Effective 04/01/2017

Injectables/Medications Administered Under the Medical Benefit Authorization NOT Required List Effective 04/01/2017 Injectables/Medications Administered Under the Medical Benefit Authorization NOT Required List Effective 04/01/2017 NOTES: Claims payment is subject to member eligibility, benefit coverage and current

More information

ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY

ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY Problem Opening PACS Images on ipads or ibooks has Been Fixed Changes have been made in PROD to enable user credentials to be passed

More information

Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19

Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19 Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19 All Non-Par Provider Requests Requires Authorization Regardless of Service J0178 J0180 J0202 J0205

More information

CURRENT DRUG SHORTAGES (through February 22, 2013) CURRENT & ONGOING SHORTAGES CRITICAL SHORTAGES

CURRENT DRUG SHORTAGES (through February 22, 2013) CURRENT & ONGOING SHORTAGES CRITICAL SHORTAGES CURRENT DRUG SHORTAGES (through February 22, 2013) CRITICAL SHORTAGES Acetylcysteine Inhalation Analgesic Buprenorphine Caffeine and Ergotamine Acyclovir Meperidine Injection Adenosine Amino Acid Products

More information

Part B payment for drugs in Medicare 0

Part B payment for drugs in Medicare 0 Part B payment for drugs in Medicare 0 Introduction: The recent pilot proposal 1 on Part B drug payment from the Center for Medicare and Medicaid Innovation of CMS has met strong resistance 2 from the

More information

Active Pharmaceutical Ingredient (API) List List Updated March 1st, 2019

Active Pharmaceutical Ingredient (API) List List Updated March 1st, 2019 5-Fluorouracil 5-FU, Fluorouracil Stability Indicating HPLC-UV USP 7-keto DHEA Stability Indicating HPLC-UV Medisca Tier 1 Acetaminophen Stability Indicating HPLC-UV USP Adenosine Alprostadil PGE-1, Prostaglandin

More information

Part B payment for drugs in Medicare: Phase 1 of CMS s proposed pilot and its impact on oncology care

Part B payment for drugs in Medicare: Phase 1 of CMS s proposed pilot and its impact on oncology care Part B payment for drugs in Medicare: Phase 1 of CMS s proposed pilot and its impact on oncology care Raina H. Jain, Stephen M. Schleicher, Coral L. Atoria, Peter B. Bach Executive Summary The recent pilot

More information

OFFERâ S INJECTABLES

OFFERâ S INJECTABLES A B Page 6 7 8 9 0 C 6 7 Page 8 9 0 D E Page 6 7 8 9 F Page 6 7 8 9 G H Page 6 7 8 9 I 6 7 Page 6 8 9 0 J 6 7 Page 7 K 6 7 8 9 L Page 8 6 7 8 9 0 Page 9 6 7 8 9 0 Page 0 OFFERâ S INJECTABLES Alimentary

More information

Part B payment for drugs in Medicare 0

Part B payment for drugs in Medicare 0 Part B payment for drugs in Medicare 0 Introduction: The recent pilot proposal 1 on Part B drug payment from the Center for Medicare and Medicaid Innovation of CMS has met strong resistance 2 from the

More information

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague,

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, Supporting document for NPSA Injectables Patient Safety Alert Attached is a document

More information

Drug Name Tier Drug Name Tier

Drug Name Tier Drug Name Tier Drug Name Tier Drug Name Tier ABELCET 100 MG/20 ML VIAL 4 ACETYLCYSTEINE 10% VIAL 2 ACETYLCYSTEINE 20% VIAL 2 ACYCLOVIR 1,000 MG/20 ML VIAL 2 ACYCLOVIR 500 MG/10 ML VIAL 2 ADRUCIL 500 MG/10 ML VIAL 2 ALBUTEROL

More information

Drug Use Evaluation: Physician Administered Drugs (PADs)

Drug Use Evaluation: Physician Administered Drugs (PADs) Drug Use Research & Management Program OHA Division of Medical Assistance Programs 500 Summer Street NE, E35; Salem, OR 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Drug Use Evaluation: Physician Administered

More information

Customer Service: Shop online at

Customer Service: Shop online at Effective May 1, 2017 Item Number Changes for Pharmaceuticals Due to changes in regulatory requirements, effective May 1, 2017, some of our pharmaceuticals' units of sale will change. The table below outlines

More information

Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites.

Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. WARDS/DEPARTMENTS By: 0 01/09/019 1 of 3 Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. Scope: All Black

More information

Alaris System Profile Report RELEASED. Stepdown. VUMC - 3/18/ :20 Page 1 of 19 VUMC O, 018d997b6-R

Alaris System Profile Report RELEASED. Stepdown. VUMC - 3/18/ :20 Page 1 of 19 VUMC O, 018d997b6-R Alaris System Profile Report RELEASED Stepdown VUMC - 3/18/2013 09:20 Page 1 of 19 1. Current Data Set Status Data Set Name Hospital Name Data Set ID Data Set Status VUMC 9.4 2013 O VUMC 018d997b6-R Released

More information

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope LIST OF PRODUCTS S.No Name Form Pharmacope ia Strength Therapeutic Segment ECTIONS DRY POWDER ECTIONS & LIQUID ECTIONS 1 a b Arteether 75mg/ml 150 mg/2ml & 225 mg/3ml 2 Amikacin Sulfate IP/ 100/250/500

More information

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj.

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. 3-Ceftriaxone 250mg & Sulbactam 125mg Inj. 4-Ceftriaxone 125mg & Sulbactam 62.5mg Inj. 5-Rabeprazole

More information

Primary malignant neoplasms, not lymphatic or hematopoietic. Secondary malignant neoplasms (i.e.metastatic) Malignant neoplasm, unknown site

Primary malignant neoplasms, not lymphatic or hematopoietic. Secondary malignant neoplasms (i.e.metastatic) Malignant neoplasm, unknown site Supplementary Table 1. ICD-9-CM codes used to define cancer ICD-9 Diagnosis code 140.xx-172.xx 174.xx-195.xx 196.xx 198.xx 199.xx 200.xx-208.xx Description Primary malignant neoplasms, not lymphatic or

More information

Medicare Part B Covered Medications

Medicare Part B Covered Medications This table provides a reference guide for the most frequent Part B/D coverage determination scenarios facing Part D plans and Part D pharmacy providers. It does not address all potential situations. For

More information

Subject: Palonosetron Hydrochloride (Aloxi )

Subject: Palonosetron Hydrochloride (Aloxi ) 09-J0000-87 Original Effective Date: 02/15/09 Reviewed: 07/09/14 Revised: 03/15/18 Subject: Palonosetron Hydrochloride (Aloxi ) THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION, EXPLANATION

More information

Active Pharmaceutical Ingredient (API) List List Updated 03/08/2018

Active Pharmaceutical Ingredient (API) List List Updated 03/08/2018 5-Fluorouracil HPLC/ UHPLC Yes USP 4017 30 5mL 2 7-keto DHEA HPLC/ UHPLC Yes Medisca 4258 180 5mL 1 Acetaminophen HPLC/ UHPLC Yes USP 4406 5mL 2 Acetylcysteine HPLC/ UHPLC Yes USP 4255 60 5mL 1 Adenosine

More information

High Risk Medications

High Risk Medications Department Policy Code: D: MM-5705 Entity: Fairview Health Services Department: Home Infusion Manual: Policies & Procedures Category: Medication Management Subject: High Risk Medications Purpose: To provide

More information

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No.

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No. LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR 2017-2018 (Non-Prequalified Items) A: Injection Antimicrobials Sr. 1 Amphotericin B vial of 50mg with wfi individually packed in carton with 2 Artemether 80mg/ml

More information

1 17 ACITRETIN 10MG CAP 20, ,000 14,000 4, ACITRETIN 25MG CAP 50, ,000 35,000 10,000

1 17 ACITRETIN 10MG CAP 20, ,000 14,000 4, ACITRETIN 25MG CAP 50, ,000 35,000 10,000 ردیف کد ژنریک نام ژنریک مبلغ پوشش وزارت بهداشت مبلغ پوشش بیمه مبلغ پرداخت بیمار درصد پرداخت بیمار قیمت اعالمی وزارت بهداشت نام تجاری 1 17 ACITRETIN 10MG CAP 20,000 10.0 2,000 14,000 4,000 2 18 ACITRETIN

More information

Subject: Fosnetupitant-Palonosetron (Akynzeo) IV

Subject: Fosnetupitant-Palonosetron (Akynzeo) IV 09-J3000-01 Original Effective Date: 06/15/18 Reviewed: 05/09/18 Revised: 01/01/19 Subject: Fosnetupitant-Palonosetron (Akynzeo) IV THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION,

More information

Exhibit B United States Patent Application 20020012663 Kind Code A1 Waksal, Harlan W. January 31, 2002 Treatment of refractory human tumors with epidermal growth factor receptor antagonists Abstract A

More information

MEDICAL NECESSITY GUIDELINE

MEDICAL NECESSITY GUIDELINE PAGE: 1 of 10 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted

More information

NOTICES DEPARTMENT OF HEALTH

NOTICES DEPARTMENT OF HEALTH NOTICES DEPARTMENT OF HEALTH Approved Drugs for ALS Ambulance Services [42 Pa.B. 4229] [Saturday, July 7, 2012] Under 28 Pa. Code 1005.11(b) (relating to drug use, control and security), the following

More information

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015 J0129 Injection, abatacept (Orencia ), 10 J0178 Injection, aflibercept (Eylea ), 1 J0256 J0257 J0585 J0586 J0587 J0588 J0597 J0641 J0717 J0800 Injection, alpha 1-proteinase inhibitor, human (Aralast NP,

More information

Guidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients

Guidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients Guidelines on Chemotherapy-induced Nausea Vomiting in Pediatric Cancer Patients COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER For

More information

VMG Pharmaceuticals Pvt. Ltd.

VMG Pharmaceuticals Pvt. Ltd. S. No. Product Name S trength Dos age form Oncology 1 A nastrazole 1 mg Tablets 2 Bicalutamide 50 mg Tablets 3 Bleomycin 15units,30units Injection 4 Bortezomib 3.5 mg Injection 5 Capecitabine 500 mg Tablets

More information

MDwise Self-Administered Codes for Medical

MDwise Self-Administered Codes for Medical The following codes are associated with medications that can be self-administered by the patient or a caregiver. As a result, MDwise will transfer coverage of these self-administered medications exclusively

More information

SCI. SickKids-Caribbean Initiative Enhancing Capacity for Care in Paediatric Cancer and Blood Disorders

SCI. SickKids-Caribbean Initiative Enhancing Capacity for Care in Paediatric Cancer and Blood Disorders 1.0 Introduction The (SCI) is a not-for-profit collaboration between the Hospital for Sick Children (SickKids), Toronto, Canada, and seven Caribbean health care institutions across six countries that strive

More information

A9542 A9543 A9545 A9699 J0120 J0128 J0129 J0130

A9542 A9543 A9545 A9699 J0120 J0128 J0129 J0130 Procedure Code 90378 A9542 A9543 Procedure Description Long RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN (RSV-IGIM), FOR INTRAMUSCULAR USE, 50 MG, EACH INDIUM IN-111 IBRITUMOMAB TIUXETAN, DIAGNOSTIC, PER

More information

Injections Requiring Prior Authorization

Injections Requiring Prior Authorization At VIVA Health, we strive to keep our provider network informed of any changes. Most of you may currently obtain prior authorizations for administered injections. Below is a list of injection, infusion,

More information

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting Definitions Acute nausea and vomiting Delayed nausea and vomiting Anticipatory nausea and vomiting Initial

More information

Guidelines for the Use of Anti-Emetics with Chemotherapy

Guidelines for the Use of Anti-Emetics with Chemotherapy Guidelines for the Use of Anti-Emetics with The purpose of this document is to provide guidance on the rational use of anti-emetics for prevention and treatment of chemotherapy-induced nausea and vomiting

More information

Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A

Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A Supportive Care in Cancer Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A Systematic Review of the Medicare Database Romina Sosa, Shuling Li, Julia T. Molony, Jiannong

More information

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT The following medications may be covered under your medical benefit if they are provided to you in your doctor s office or outpatient infusion

More information

AMMONIA AROMATIC 15 % (W/V) SOLUTION FOR

AMMONIA AROMATIC 15 % (W/V) SOLUTION FOR NDC Code HCPCS Code Medication Name & Amount Inpatient Fee 00904525646 J8499 ACETAMINOPHEN 80 MG CHEWABLE TABLET 1.00 00904198261 J3490 ACETAMINOPHEN 325 MG TABLET 1.00 50580050110 J3490 ACETAMINOPHEN

More information

Release of the 2017/18 Invitation to Tender

Release of the 2017/18 Invitation to Tender 2 November 2017 Release of the 2017/18 Invitation to Tender The 2017/18 Invitation to Tender (2017/18 ITT) has been distributed today. If you have already registered your e-mail address with PHARMAC s

More information

Subject: NK-1 receptor antagonist injectable therapy (Emend, Cinvanti, Varubi )

Subject: NK-1 receptor antagonist injectable therapy (Emend, Cinvanti, Varubi ) 09-J2000-60 Original Effective Date: 06/15/16 Reviewed: 04/11/18 Revised: 01/01/19 Subject: NK-1 receptor antagonist injectable therapy (Emend, Cinvanti, Varubi ) THIS MEDICAL COVERAGE GUIDELINE IS NOT

More information

Regional. Parenteral Manual. Usage Guidelines

Regional. Parenteral Manual. Usage Guidelines Regional Parenteral Manual Usage Guidelines 1. Background and Objectives... 2 2. Off-Label Use of Drugs... 3 3. Abbreviations for Monographs and Definitions... 4 3.1 Abbreviations for Regional Parenteral

More information

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

HCPCS Code/ generic (Brand) Name J7506. J8520 capecitabine (Xeloda) 1. J8521 capecitabine. J8530 cyclophosphamide. (Cytoxan) 1

HCPCS Code/ generic (Brand) Name J7506. J8520 capecitabine (Xeloda) 1. J8521 capecitabine. J8530 cyclophosphamide. (Cytoxan) 1 drug and administration compendia Current Price () J7506 Prednisone, oral, per 5 mg 12/1/07 $0.07 $0.19 N/A prednisone 2 J8520 capecitabine (Xeloda) 1 Capecitabine, oral, 150 mg 8/1/07 $5.79 $4.59 N/A

More information

Injection Dosage Calculations

Injection Dosage Calculations INJECTIONS: QUIZ 3 Injection Dosage Calculations 1. A child is ordered 9 mg of gentamicin by IM. Stock ampoules contain 20 mg in 2 ml. What volume is needed for the injection? a. 0.9 ml b. 0.5 ml c. 2.2

More information

Managements of Chemotherpay Induded Nausea and Vomiting

Managements of Chemotherpay Induded Nausea and Vomiting REVIEW ARTICLE Managements of Chemotherpay Induded Nausea and Vomiting Department of Surgery, The Catholic University of Korea Sung Geun Kim 23 24 Sung Geun Kim Korean Journal of Clinical Oncology Summer

More information

Rajasthan Medical Services Corporation Limited, Jaipur

Rajasthan Medical Services Corporation Limited, Jaipur Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV

More information

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017 Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and

Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and 35 Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and Biologically directed therapies ) 1 1- Nausea and vomiting

More information

UP Health System Marquette Medication Guideline High Alert Drugs

UP Health System Marquette Medication Guideline High Alert Drugs 1 ALTEPLASE SOLR 100 MG ACTIVASE 305010 50242008527 TRUE ALTEPLASE SOLR 50 MG ACTIVASE 305008 50242004413 TRUE AMIODARONE INJ 50 MG/ML CORDARONE IV 305035 63323061609 TRUE AMIODARONE INJ 50 MG/ML CORDARONE

More information

Product List Finished Dosage Forms (FDF) B2B Business

Product List Finished Dosage Forms (FDF) B2B Business Product List 2017 Finished Dosage Forms (FDF) B2B Business Anaesthetics Dermatology Lidocaine Lidocaine and Prilocaine Dexmedetomidine Hydrochloride Anti-Infectives Amoxicillin Trihydrate and Potassium

More information

Appendix 4: Renal impairment

Appendix 4: Renal impairment Appendix 4: Renal impairment Reduced renal function may cause problems with drug therapy for the following reasons: 1. The failure to excrete a drug or its metabolites may produce toxicity. 2. The to some

More information

IHCP banner page INDIANA HEALTH COVERAGE PROGRAMS BR FEBRUARY 16, 2016

IHCP banner page INDIANA HEALTH COVERAGE PROGRAMS BR FEBRUARY 16, 2016 IHCP banner page INDIANA HEALTH COVERAGE PROGRAMS BR201607 FEBRUARY 16, 2016 HCPCS code J1458 linked to revenue code 636 Effective March 16, 2016, the Indiana Health Coverage Programs (IHCP) will link

More information

CURRENT DRUG SHORTAGES (through October 14, 2014)

CURRENT DRUG SHORTAGES (through October 14, 2014) CRITICAL SHORTAGES at Methodist Ammonium Chloride Injection Analgesic Buprenorphine Sublingual Tablets Azathioprine Injection Buprenorphine Injection Barium Sulfate Suspension Butorphanol Becapler Gel

More information

Fee* Effective CPT Code Short Description

Fee* Effective CPT Code Short Description 90281 HUMAN IG, IM $70.38 90283 HUMAN IG, IV $42.84 90284 HUMAN IG, SC $10.71 90291 CMV IG, IV $1,311.21 90371 HEP B IG, IM $131.58 90375 RABIES IG, IM/SC $307.53 90376 RABIES IG, HEAT TREATED $338.13

More information

Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)

Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe) Drug Max dose approved for IVP Dilution Rate Monitoring Parameters Acetazolamide 500 mg Reconstitute with at least 5ml sterile water (max concentration should not exceed 100mg/ml) 100-500 mg/min Hypotension

More information

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017 Drug Category Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Riesbeck's Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml 2160ml Hydroxyzine

More information

GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION

GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY More than half of all cancer patients experience nausea or vomiting during the course of their treatment. If nausea or vomiting becomes severe enough,

More information

Emetogenicity level 1. Emetogenicity level 2

Emetogenicity level 1. Emetogenicity level 2 Emetogenicity level 1 15 mins Pre-Chemo Maxalon 10mg po During chemo and Post Chemo 3 days Maxalon10mg po 8 hourly Increase Maxalon 20mg po 8 hourly Change to Cyclizine 50mg po 8 hourly 3 days If nausea

More information

Critical Care Standard Infusion Concentrations

Critical Care Standard Infusion Concentrations Acetylcisteine (NAC) Actrapid - Human Insulin Addiphos 20mmol Addiphos 40mmol Adrenaline (Epinephrine) vs peripheral 10 g in 50mL 200mg per ml 50 units in 50mL 1 unit per ml sodium chloride 20 mmol in

More information

Fee* Effective CPT Code Short Description 02/15/2017

Fee* Effective CPT Code Short Description 02/15/2017 90281 HUMAN IG, IM $70.38 90283 HUMAN IG, IV $45.14 90284 HUMAN IG, SC $11.48 90291 CMV IG, IV $1,311.21 90371 HEP B IG, IM $131.58 90375 RABIES IG, IM/SC $307.53 90376 RABIES IG, HEAT TREATED $368.73

More information

MASCC Guidelines for Antiemetic control: An update

MASCC Guidelines for Antiemetic control: An update MASCC / ISOO 17 th International Symposium Supportive Care in Cancer June 30 July 2, 2005 / Geneva, Switzerland MASCC Guidelines for Antiemetic control: An update Sussanne Börjeson, RN, PhD Linköping University,

More information

Professionalism & Service with Great Prices

Professionalism & Service with Great Prices Acyclovir Capsules 200mg Viruses 30 90 Albuterol Syrup 2mg/5ml Asthma 120 360 Albuterol Sulfate Solution 0.05% * Asthma ----- ----- 20 60 Albuterol Sulfate Solution 0.083% Asthma ----- ----- 75 225 Alendronate

More information

Committee Approval Date: December 12, 2014 Next Review Date: July 2015

Committee Approval Date: December 12, 2014 Next Review Date: July 2015 Medication Policy Manual Policy No: dru378 Topic: Akynzeo, netupitant/palonosetron Date of Origin: December 12, 2014 Committee Approval Date: December 12, 2014 Next Review Date: July 2015 Effective Date:

More information

Haematology, Oncology and Palliative Care Directorate.

Haematology, Oncology and Palliative Care Directorate. Anticancer Treatment for Administration on the Somerset Mobile Chemotherapy Unit The table below details the suitability of different types of anticancer treatment for administration on the Somerset Mobile

More information

PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014

PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014 PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014 The Prescription Savings Club provides its members with significant savings on prescription medications. The

More information

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced Class Medicine Name Nappi Strength Form Size Route Abiraterone Acetate ZYTIGA

More information

Cancer SLO Practice (online set) Page 1 of 5

Cancer SLO Practice (online set) Page 1 of 5 Cancer SLO Practice (online set) Page 1 of 5 1. Aranesp is? A. Darbepoetin alfa B. Filgrastim C. Epoetin alfa D. Sargramostim E. Pegfilgrastim 2. BCNU is? B. Cyclophosphamide 3. Bleomycin is a natural

More information

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers

Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers This formulary is current as of February 11, 2010. Important Notes: Pharmacists must submit a claim on PharmaNet at the time

More information

CPT Service Description Effective Date

CPT Service Description Effective Date Medical Oncology Program Review Code List 2 nd Quarter 2018 This list is subject to change once per quarter. Changes will be posted to the BCBSNC website at www.bcbsnc.com by the 10th day of January, April,

More information

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List Code Drug Name Effective and/or Term Date J0129 Injection, abatacept (Orencia ), 10 mg J0178 Injection, aflibercept (Eylea

More information

1 ( concentrated electrolytes ) ก

1 ( concentrated electrolytes ) ก ก ก HAD 1 ( concentrated electrolytes ) ก ก ก ( ) ก ก ก ก 2 ก ก ก (Patient care unit) ก ก ก ก ( Hemodialysis ) ก ก ก ก ก ก stock card ก ก ( High Alert Drug (HAD)) ก ก ก ก (Pharmacy and Therapeutic Committee

More information

Fruth Pharmacy Prescription Savings Club Prescription Club October 2010 Generics item list 30 Day Qty

Fruth Pharmacy Prescription Savings Club Prescription Club October 2010 Generics item list 30 Day Qty Fruth Pharmacy Prescription Savings Club Prescription Club October 2010 Generics item list Antihistamine Drugs Cyproheptadine HCl Tab 4 mg Anti-Infective Agents Diphenhydramine HCl Cap mg Promethazine

More information

TennCare Program TN MAC Price Change List As of: 03/30/2017

TennCare Program TN MAC Price Change List As of: 03/30/2017 1 TN List Run : 03/30/17 Old PRAZOSIN HCL 5 MG CAPSULE ORAL 03/29/2017 1.11209 1.12560 ( 1.2) CAPTOPRIL 12.5 MG TABLET ORAL 07/07/2015 1.07191 1.10416 ( 2.9) ISOSORBIDE DINITRATE 5 MG TABLET ORAL 03/29/2017

More information

Drug Schedule For RC 143(A)

Drug Schedule For RC 143(A) DRUGS FOR RESPIRATORY SALBUTAMOL TAB - Each Tab to SYSTEM 1 30a contain:salbutamol 2mg. 1 tab 9600000 100000 200000 SALBUTAMOL TAB - Each Tab to 2 30b contain:salbutamol 4 mg. 1 tab 8000000 80000 160000

More information

Release of the 2014/15 Invitation to Tender

Release of the 2014/15 Invitation to Tender 6 November 2014 Release of the 2014/15 Invitation to Tender The 2014/15 Invitation to Tender (2014/15 ITT) has been distributed today. Please note that the Electronic Portal will not be available until

More information

Guideline Update on Antiemetics

Guideline Update on Antiemetics Guideline Update on Antiemetics Clinical Practice Guideline Special Announcements Please check www.asco.org/guidelines/antiemetics for current FDA alert(s) and safety announcement(s) on antiemetics 2 Introduction

More information

NICU Guidebook TABLE OF CONTENTS

NICU Guidebook TABLE OF CONTENTS NICU Guidebook TABLE OF CONTENTS Medications Antibiotics o Acyclovir o Amoxicillin o Amphotericin B Deoxycholate o Amphotericin B Liposomal o Ampicillin o Azithromycin o Aztreonam o Cefazolin o Cefepime

More information

Highmark List of Procedure Codes Requiring NDC Effective 12/01/2017

Highmark List of Procedure Codes Requiring NDC Effective 12/01/2017 90378 RESPIRATORY SYNCYTIAL VIRUS, MONOCLONAL ANTIBODY, RECOMBINANT, FOR INTRAMUSCULAR USE, 50 MG, EACH C9399 Unclassified Drugs or biologicals J0129 INJECTION, ABATACEPT, 10 MG J0130 INJECTION ABCIXIMAB,

More information

PARENTERAL NUTRITION: CLEARING UP THE ISSUES

PARENTERAL NUTRITION: CLEARING UP THE ISSUES Nutrition Dilemmas, PARENTERAL NUTRITION: CLEARING UP THE ISSUES Frequent questions/issues that need to be settled Should all total parenteral solutions be infused within 24 hours? Can we allow beyond-

More information

INJECTION, INOTUZUMAB OZOGAMICIN, 0.1 MG [BESPONSA ] [C CODES FOR FACILITY USE ONLY]

INJECTION, INOTUZUMAB OZOGAMICIN, 0.1 MG [BESPONSA ] [C CODES FOR FACILITY USE ONLY] Commercial Medical Oncology Program Review Code List 3rd Quarter 2018 This list is subject to change once per quarter. Changes will be posted to the BCBSNC website at www.bcbsnc.com by the 10th day of

More information

Tall Man Lettering. Contracted community pharmacies whose software is unable to accommodate the Tall Man lettering.

Tall Man Lettering. Contracted community pharmacies whose software is unable to accommodate the Tall Man lettering. Approved by: Tall Man Lettering Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: VII-B-340 Date Approved November 23,

More information

Miracalus Pharma Pvt Limited

Miracalus Pharma Pvt Limited Dealers in Vaccines, TPN, Blood products and All Anti-Cancer Drugs Miracalus Pharma Pvt Limited ANTI CANCER - Injections ING CISPLATIN 10MG CISTEEN 1 VIAL ING CISPLATIN 50MG CISTEEN 1 VIAL INJ 5 FLURO

More information

1 ml) (100 x. 10 ml)

1 ml) (100 x. 10 ml) SCHEDULE COPY NICIPAL CORPORATION OF GREATER MUM NTRAL PURCHASE AUTHORITY DEPARTME SCHEDULE I OF 2010-2011 INJECTIONS & SERA VACCINES CONTRACT PERIOD : 1-1-2010 To 31-12-2011 Item Description Quantity

More information

Appendix 5: Hepatic impairment

Appendix 5: Hepatic impairment Appendix 5: Hepatic impairment Liver disease may alter the response to drugs. However, the hepatic reserve appears to be large and liver disease has to be severe before important changes in drug metabolism

More information

Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients

Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients POGO Antineoplastic Induced Nausea and Vomiting Guideline Development Panel: L.

More information

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets

More information

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Product Name Strength Dosage Form Therapeutic Area Dossier Status Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Alendronate Sodium 10/70mg Tablets Osteoporosis Approved Anastrozole

More information

BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description. mfctr allocation.

BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description. mfctr allocation. September 28, 2018 Pharmaceutical Backorder Report BT item # Description Mfctr ETA for next release Date Mfctr expects back orders to clear Possible sub ** Description 0542-02 Adenosine 6mg, 2ml Vial (limited

More information

Nebraska Medicaid Program NE Weekly MAC Price Change List For Period: 12/14/ /20/2017

Nebraska Medicaid Program NE Weekly MAC Price Change List For Period: 12/14/ /20/2017 1 Medicaid Run : 12/21/17 NE Weekly List Old AMIODARONE HCL 200 MG TABLET ORAL 12/20/2017 0.15321 0.14370 6.6 HYDRALAZINE HCL 10 MG TABLET ORAL 12/20/2017 0.05226 0.05213 0.2 LISINOPRIL 10 MG TABLET ORAL

More information

$4 Prescription Program October 23, 2007

$4 Prescription Program October 23, 2007 Allergies & Cold and Flu Benzonatate 100mg 14 Ceron DM syrup Ceron drops Dec-Chlorphen drops Dec-Chlorphen DM syrup 118ml* Loratadine 10mg Promethazine DM syrup Trivent DPC syrup * Antibiotic Treatments

More information

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies:

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies: VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Incidence: The incidence of acute and delayed N&V was investigated in highly and moderately emetogenic

More information

$4 Prescription Program May 5, 2008

$4 Prescription Program May 5, 2008 Allergies & Cold and Flu Benzonatate 100mg 14 42 Ceron DM syrup 120ml 360ml Ceron drops* 30ml 90ml Dec-Chlorphen drops* 30ml 90ml Dec-Chlorphen DM syrup* 118ml 354ml Loratadine 10mg 30 90 Promethazine

More information

UTMB DEPARTMENT OF PHARMACY POLICY AND PROCEDURES Section Medication Use ADMINISTRATION OF MEDICATION BY IV PUSH

UTMB DEPARTMENT OF PHARMACY POLICY AND PROCEDURES Section Medication Use ADMINISTRATION OF MEDICATION BY IV PUSH Page 1 of 8 ADMINISTRATION OF MEDICATION BY IV PUSH AUDIENCE POLICY This document is directed to Registered Nurses (RNs), Licensed Vocational Nurses (LVN s), and physicians. The following delineates the

More information